Concepedia

Robert L. Walsky

RL

Statistics

Publications

29

Citations

3.3K

H-Index

25

Active since

1968

Affiliations

Pfizer (United States)(Current)

La Roche College

Eisai (United States)

Vertex Pharmaceuticals (United States)

Eli Lilly (United States)

Robert L. Walsky is an author at Pfizer (United States) specializing in pharmacology, pharmacokinetics, and medicine.

Publications per year

1968–2020

29

Publications

29

VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES

Robert L. Walsky, R. Scott Obach · Drug Metabolism and Disposition · 2004 · 504 citations

, , +15

Mechanism-Based Inactivation of Human Cytochrome P450 Enzymes and the Prediction of Drug-Drug Interactions

R. Scott Obach, Robert L. Walsky, Karthik Venkatakrishnan · Drug Metabolism and Disposition · 2006 · 456 citations

, , +17

The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions

R. Scott Obach, Robert L. Walsky, Karthik Venkatakrishnan et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 437 citations

, , +17

Examination of 209 Drugs for Inhibition of Cytochrome P450 2C8

Robert L. Walsky, Emily A. Gaman, R. Scott Obach · The Journal of Clinical Pharmacology · 2004 · 187 citations

, , +17

SELECTIVE INHIBITION OF HUMAN CYTOCHROME P4502C8 BY MONTELUKAST

Robert L. Walsky, R. Scott Obach, Emily A. Gaman et al. · Drug Metabolism and Disposition · 2004 · 163 citations

, , +17

1–5 of 29